| Code | Description | Claims | Beneficiaries | Total Paid |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
121 |
108 |
$231K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,194 |
2,116 |
$87K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
677 |
626 |
$32K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
219 |
216 |
$5K |
| 96415 |
|
392 |
357 |
$4K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
113 |
100 |
$258.78 |